SHARPIN and metabolic dysfunction-associated steatohepatitis: In a mouse model of nonalcoholic steatohepatitis (NASH), hepatic fatty acid accumulation likely disrupts LUBAC assembly by reducing SHARPIN expression, thereby impairing downstream NF-κB activation [171].